228850.KQ Rayence Co. Ltd

Healthcare Health Care Equipment & Supplies KOSDAQ
7,690 KRW
Close of Oct 31, 2026
4,835 8,750
Market cap
KRW 121B
P/E
30.2x
P/B
0.50x
ROE
7.0%
Dividend yield
1.30%
Fundamental score
1.1/5

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is 228850.KQ undervalued?

Graham number
Price7,690
Graham value9,382
Discount18.0%

228850.KQ trades 18.0% below its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Rayence Co. Ltd fundamental analysis

6 of 22 checks passed

ROE 0/2

Low return on equity (7.0%), below 10%.

ROA 0/1

Return on assets (6.2%) is below the industry median (6.2%).

Profit Consistency 0/2

Not profitable for at least 3 consecutive years.

Earnings Growth 5Y 0/1

Earnings per share did not grow over the past 5 years.

Earnings Acceleration 0/1

Not enough positive earnings history to compare last year's growth with the 5-year average.

Earnings Growth vs Industry 0/1

Last year's EPS growth (-167.5%) is below the industry median (0.5%).

Revenue Growth 0/2

Revenue shrank 8.0% a year over the past 3 years.

Short-term Liquidity 1/1

Current assets cover short-term liabilities.

Long-term Liabilities 1/1

Current assets cover long-term liabilities.

Debt to Equity 0/2

Debt to equity cannot be calculated: debt is not reported or equity is negative.

Debt Trend 0/1

Debt to equity has risen over the past 5 years.

Debt Coverage 0/1

Debt is not reported.

Interest Coverage 1/1

EBIT is 62.7x against interest expense, well covered.

PE vs Market 0/1

PE (30.2x) is above the market median (11.3x).

PE vs Industry 0/1

PE (30.2x) is above the industry median (7.6x).

PBV 1/1

Price to book (0.5x) is below the industry median (0.7x).

Graham Number 1/1

The price is below the Graham number (PE x PB = 15.1, limit 22.5).

PEG 0/1

PEG needs positive PE and positive 5-year earnings growth.

Dividend Yield 1/2

Dividend yield (1.3%) is above the bottom 25% of dividend payers in the market.

Dividend Stability 0/2

Dividends were not paid steadily for the past 5 years.

Dividend Growth 0/1

Dividends paid did not grow over the past 5 years.

Payout Ratio 0/1

No dividend, or no profit to pay it from.

Each check is worth 1 or 2 points by how much it says about the quality of the company. The score is the share of points earned, out of 5. Ask AI to explain this score

Rayence Co. Ltd stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Rayence Co. Ltd

Rayence Co., Ltd., together with its subsidiaries, engages in the development, manufacture, and sale of digital X-ray detector products for dental, medical, veterinary, and industrial sectors in South Korea, the United States, Mexico, China, and internationally. The company offers TFT/CMOS X-ray detectors for general radiography, C-arm/RF, mammography, and radiotherapy; and CMOS/Super IGZO TFT/a-Si TFT X-ray detectors for applications, such as dental, veterinary, AXI, die-ca…

Full company profile